Asston Pharmaceuticals (BOM:544445) Beta: N/A (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544445 Asston Pharmaceuticals Ltd BOM:544445
19 GF Score
Price ₹67.00
! 3 Warning Signs
View Full Analysis

What is Asston Pharmaceuticals Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-02), Asston Pharmaceuticals's Beta is Not available.

Asston Pharmaceuticals  (BOM:544445) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Asston Pharmaceuticals Beta Related Terms

Asston Pharmaceuticals Beta Historical Data

* Premium members only.

The historical data trend for Asston Pharmaceuticals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asston Pharmaceuticals Beta Chart

Asston Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beta
0.00 0.00 0.00 0.00 0.00

Asston Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BOM:544445
19GF Score
Asston Pharmaceuticals Ltd BOM:544445
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asston Pharmaceuticals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Asston Pharmaceuticals Business Description

Address Plot No 42A, Sector-11, 4th Floor, Office No. A-431 Balaji Bhavan, CBD Belapur, Navi Mumbai, Thane, MH, IND, 400 614
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
19GF Score

Get the complete analysis for BOM:544445

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.00
Price